Physician profile
Steven E Hansen
NPI 1285628412
$3,726.50
in general payments reported to CMS, 2019-2025
16 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Corneal and Contact Management provider received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $230 · 2021: $391 · 2022: $773 · 2023: $650 · 2024: $623 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,595.35 | 2019-2025 | Hydrus Microstent, Total30, Rocklatan |
| Coopervision INC. | $455.93 | 2019-2025 | Misight Contact Lens |
| Ivantis, INC | $279.54 | 2019-2021 | |
| Allergan, INC. | $273.07 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $231.95 | 2023-2024 | Infuse |
| Novartis Pharmaceuticals Corporation | $161.54 | 2019-2023 | |
| Shire North American Group INC | $148.88 | 2019 | |
| Aerie Pharmaceuticals, INC. | $132.10 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $119.01 | 2019-2023 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.99 | 2020 | |
| Oyster Point Pharma, INC. | $70.06 | 2022-2024 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $58.48 | 2024 | |
| Abbvie INC. | $31.55 | 2022-2024 | |
| Thea Pharma INC. | $17.66 | 2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $17.34 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $15.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.